Literature DB >> 1260179

Investigation of occurrence of tolerance to bronchodilator drugs in chronically pretreated guinea-pigs.

A A Anderson, G M Lees.   

Abstract

1 The actions of sympathomimetic amines on isolated preparations of atria, trachea and ileum were studied in vitro in guinea-pigs, which had been pretreated for 5 or 12 days, by subcutaneous injection, with adrenaline (5 mug/kg), salbutamol (0.5 mug/kg), salbutamol (0.5 mug/kg), methoxamine (250 mug/kg) or saline (0.9% w/V NaCl solution). 2 In the trachea, a decrease in sensitivity (tolerance) to the relaxant effect of adrenaline was induced by pretreatment, for 12 but not for 5 days, with adrenaline. In these animals, cross-tolerance to isoprenaline or salbutamol was not observed. Tolerance to the relaxant actions of adrenaline isoprenaline or salbutamol was not observed after pretreatment with salbutamol. 3 In the trachea, pretreatment with methoxamine or adrenaline for 12 days did not change the sensitivity to the alpha-adrenoceptor-mediated contractor action of methoxamine. 4 In the atria from those guinea-pigs pretreated with adrenaline or salbutamol, there was no reduced sensitivity to the beta-adrenoceptor agonist actions of adrenaline, isoprenaline or salbutamol. In animals pretreated with methoxamine or adrenaline, there was no observable tolerance or cross tolerance to methoxamine with respect to its alpha-adrenoceptor-mediated positive inotropic action in the atria and no unequivocal evidence of a reduced sensitivity to that action of adrenaline. 5 It was confirmed that the twitch-like contractions of the longitudinal muscle of the electrically stimulated ileum were inhibited by sympatomimetic amines acting on alpha- and beta-adrenoceptors. There was no reduced sensitivity to the inhibitory actions of noradrenaline or isoprenaline on the twitch of ileum isolated from animals pretreated with adrenaline, salbutamol or methoxamine for 5 or 12 days. 6 From our results on these three preparations from the same animals, it is concluded that generalizations regarding changes in sensitivity to sympathomimetic amines following their prolonged administration should not be made in any one species.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1260179      PMCID: PMC1666927          DOI: 10.1111/j.1476-5381.1976.tb07647.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Tolerance to sympathomimetic bronchodilators in the guinea pig lungs.

Authors:  C J Benoy; M S Fellah; R Schneider; O L Wade
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

2.  Adrenergic receptors on some organs.

Authors:  K Takagi; E Osada; I Takayanagi; F Taga
Journal:  Arch Int Pharmacodyn Ther       Date:  1967-07

3.  Myocardial alpha adrenergic receptors and their role in the production of a positive inotropic effect by sympathomimetic agents.

Authors:  W C Govier
Journal:  J Pharmacol Exp Ther       Date:  1968-01       Impact factor: 4.030

4.  Thymoxamine and airways obstruction.

Authors:  J P Griffin; P L Kamburoff; F J Prime; A G Arbab
Journal:  Lancet       Date:  1972-06-10       Impact factor: 79.321

5.  Further observations on the cardiotoxicity of isoprenaline during hypoxia.

Authors:  D G McDevitt; R G Shanks; J G Swanton
Journal:  Br J Pharmacol       Date:  1974-03       Impact factor: 8.739

6.  Isoprenaline-induced tachycardia in man.

Authors:  P J Kingsley; D W Littlejohns; B N Prichard
Journal:  Br J Pharmacol       Date:  1972-11       Impact factor: 8.739

7.  Inhibition of rabbit intestine mediated by alpha- and beta-adrenoceptors.

Authors:  W C Bowman; M T Hall
Journal:  Br J Pharmacol       Date:  1970-02       Impact factor: 8.739

8.  Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths).

Authors:  M E Conolly; D S Davies; C T Dollery; C F George
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

9.  Investigation into use of drugs preceding death from asthma.

Authors:  F E Speizer; R Doll; P Heaf; L B Strang
Journal:  Br Med J       Date:  1968-02-10

10.  Comparison of the bronchodilator and cardiovascular actions of salbutamol, isoprenaline and orciprenaline in guinea-pigs and dogs.

Authors:  M J Daly; J B Farmer; G P Levy
Journal:  Br J Pharmacol       Date:  1971-11       Impact factor: 8.739

View more
  8 in total

Review 1.  A hitch-hiker's guide to the galaxy of adrenoceptors.

Authors:  G M Lees
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-18

2.  Distribution and types of adrenoceptors in the guinea-pig ileum: the action of alpha- and beta-adrenoceptor agonists.

Authors:  V Bauer
Journal:  Br J Pharmacol       Date:  1981-02       Impact factor: 8.739

3.  Sublingual isoprenaline in treatment of primary pulmonary hypertension: discussion paper.

Authors:  J F Ackroyd
Journal:  J R Soc Med       Date:  1985-06       Impact factor: 5.344

4.  Pharmacological characterization of the presynaptic alpha-adrenoceptors regulating cholinergic activity in the guinea-pig ileum.

Authors:  G M Drew
Journal:  Br J Pharmacol       Date:  1978-10       Impact factor: 8.739

5.  Distribution and types of adrenoceptors in the guinea-pig ileum: the action of alpha- and beta-adrenoceptor blocking agents.

Authors:  V Bauer
Journal:  Br J Pharmacol       Date:  1982-08       Impact factor: 8.739

6.  Effects of 3,4-diaminopyridine and tetraethylammonium on the pre- and post-junctional alpha-adrenoceptor mediated inhibitory actions of noradrenaline in the guinea-pig ileum.

Authors:  V Bauer
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

7.  Homogeneous and non-homogeneous distribution of inhibitory and excitatory adrenoceptors in the longitudinal muscle of the guinea-pig ileum.

Authors:  V Bauer; H Kuriyama
Journal:  Br J Pharmacol       Date:  1982-08       Impact factor: 8.739

8.  Tolerance of guinea-pig airway muscle preparations to relaxant agonists induced by chronic exposure to isoprenaline in vivo.

Authors:  C Brink
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.